Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/266037
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS) |
Autor: | Benavent, Marta CSIC ORCID; Sastre, Javier CSIC ORCID; García-Escobar, Ignacio; Segura, Ángel; Capdevila, Jaume; Carmona, Alberto; Sevilla, Isabel; Alonso Gordoa, Teresa; Crespo, Guillermo; García, Lourdes; Canal, Neus; Cruz-Sugranyes, Guillermo de la; Gallego, Javier CSIC | Palabras clave: | Neuroendocrine tumours Health-related quality of life QLQ-GINET21 questionnaire Communication Clinical utility |
Fecha de publicación: | 30-ene-2021 | Editor: | BioMed Central | Citación: | Health and Quality of Life Outcomes 19: 38 (2021) | Resumen: | [Background and objective] Patient-reported outcome measures can provide clinicians with valuable information to improve doctor-patient communication and inform clinical decision-making. The aim of this study was to evaluate the physician-perceived utility of the QLQ-GINET21 in routine clinical practice in patients with gastrointestinal neuroendocrine tumours (GI-NETs). Secondary aims were to explore the patient, clinician, and/or centre-related variables potentially associated with perceived clinical utility. [Methods] Non-interventional, cross-sectional, multicentre study conducted at 34 hospitals in Spain and Portugal (NCT02853422). Patients diagnosed with GI-NETs completed two health-related quality of life (HRQoL) questionnaires (QLQ-C30, QLQ-GINET21) during a single routine visit. Physicians completed a 14-item ad hoc survey to rate the clinical utility of QLQ-GINET21 on three dimensions: 1)therapeutic and clinical decision-making, 2)doctor-patient communication, 3)questionnaire characteristics. [Results] A total of 199 patients at 34 centres were enrolled by 36 participating clinicians. The highest rated dimension on the QLQ-GINET21 was questionnaire characteristics (86.9% of responses indicating “high utility”), followed by doctor-patient communication (74.4%), and therapeutic and clinical decision-making (65.8%). One physician-related variable (GI-NET patient volume > 30 patients/year) was associated with high clinical utility and two variables (older age/less experience treating GI-NETs) with low clinical utility. [Conclusions] Clinician-perceived clinical utility of QLQ-GINET21 is high. Clinicians valued the instruments’ capacity to provide a better understanding of patient perspectives and to identify the factors that had the largest influence on patient HRQoL. |
Versión del editor: | http://dx.doi.org/10.1186/s12955-021-01688-x | URI: | http://hdl.handle.net/10261/266037 | DOI: | 10.1186/s12955-021-01688-x | Identificadores: | doi: 10.1186/s12955-021-01688-x e-issn: 1477-7525 |
Aparece en las colecciones: | (IBIS) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
EORTC_QLQ-GINET21.pdf | 1,1 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
Page view(s)
40
checked on 14-may-2024
Download(s)
52
checked on 14-may-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons